Common Stock, Shares, Outstanding of Werewolf Therapeutics, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Werewolf Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Werewolf Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 47,273,685, a 8.1% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Werewolf Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 47,273,685 +3,551,913 +8.1% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 45,335,265 +1,633,118 +3.7% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 44,827,159 +1,544,788 +3.6% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 44,827,159 +5,720,111 +15% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 43,721,772 +8,063,772 +23% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 43,702,147 +8,060,147 +23% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 43,282,371 +7,981,371 +23% 31 Mar 2024 10-Q 03 May 2024 2024 Q1
Q4 2023 39,107,048 +7,673,317 +24% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 35,658,000 +5,047,000 +16% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 35,642,000 +7,364,000 +26% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 35,301,000 +7,881,000 +29% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 31,433,731 +4,120,731 +15% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 30,611,000 +3,392,000 +12% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 28,278,000 +1,144,000 +4.2% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 27,420,000 +25,660,000 +1458% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 27,313,000 +26,129,000 +2207% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 27,219,000 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 27,134,000 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 1,760,000 31 Mar 2021 10-Q 10 Jun 2021 2021 Q1
Q4 2020 1,184,000 31 Dec 2020 10-K 24 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.